INHIBITION OF BONE EROSION, DETERMINED BY HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HR-PQCT), IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING A CONVENTIONAL SYNTHETIC DMARD (CSDMARD) PLUS DENOSUMAB VS CSDMARD THERAPY ALONE: RESULTS OF AN OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP STUDY

N. Iwamoto,K. Chiba,S. Sato, K. Shiraishi,K. Watanabe, N. Ohki, A. Okada, T. Koga, M. Kobayashi, K. Saito, N. Okubo, A. Kawakami

ANNALS OF THE RHEUMATIC DISEASES(2022)

引用 0|浏览1
暂无评分
关键词
denosumab vs csdmard therapy,rheumatoid arthritis,bone erosion,rheumatoid arthritis patients,high-resolution,hr-pqct,open-label,parallel-group
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要